Criteria for the evaluation of large cohort studies: An application to the nurses' health study

Journal of the National Cancer Institute

Volumn 100, Issue 13, 2008, Pages 918-925

  Colditz, Graham A ^a   Winn, Deborah M ^b  

^a BARNES JEWISH HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ORAL CONTRACEPTIVE AGENT; SELENIUM;

BREAST CANCER; CANCER RISK; CLINICAL RESEARCH; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; LIFESTYLE; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MEDICAL PRACTICE; NOTE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH SERVICE;

BREAST NEOPLASMS; COHORT STUDIES; COLONIC NEOPLASMS; CORONARY DISEASE; COST OF ILLNESS; DIABETES MELLITUS; EPIDEMIOLOGIC STUDIES; EVALUATION STUDIES AS TOPIC; FEMALE; HEALTH STATUS; HUMANS; HYPERTENSION; MOTOR ACTIVITY; NATIONAL CANCER INSTITUTE (U.S.); NURSES; OBESITY; SMOKING; STROKE; UNITED STATES;

EID: 46849118061     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn193     Document Type: Note

References (101)

1. National Cancer Institute. The Nation's Investment in Cancer Research for Fiscal Year 2004. Bethesda, MD: National Cancer Institute, NIH; 2003.
2. Stokols D, Fuqua J, Gress J, et al. Evaluating transdisciplinary science. Nicotine Tob Res. 2003;5(suppl 1):S21-S39.
3. von Eschenbach AC. A vision for the National Cancer Program in the United States. Nat Rev Cancer. 2004;4(10):820-828.
4. Lilienfeld AM, Lilienfeld DE. Foundations of Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1980.
5. Colditz GA, Hankinson SE. The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer. 2005;5(5):388-396.
6. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998;351:1393-1396.
7. Hankinson SE, Willett WC, Michaud DS, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1999;91(7):629-634.
8. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst. 2004;96(24):1856-1865.
9. Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst. 2003;95(5):373-380.
10. Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE. Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2335-2339.
11. Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25- hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1991-1997.
12. Jacobs T, Byrne C, Colditz G, Connolly J, Schnitt S. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med. 1999;340(6):430-436.
13. Rosner B. Multivariate methods for binary longitudinal data with heterogeneous correlation over time. Stat Med. 1992;11(14-15):1915-1928.
14. Rosner B. Measurement error models for ordinal exposure variables measured with error. Stat Med. 1996;15(3):293-303.
15. Perisic I, Rosner B. Comparisons of measures of interclass correlations: the general case of unequal group size. Stat Med. 1999;18(12):1451-1466.
16. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162(10):975-982.
17. International Agency for Research on Cancer. Overall Evaluations of carcinogenicity: An update of IARC Monographs Volumes 1 to 42. Lyon, France: IARC; 1987.
18. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med. 1987;316(19):1174-1180.
19. Hankinson S, Hunter D, Colditz G, et al. Tubal ligation, hysterectomy and risk of ovarian cancer: a prospective study. JAMA. 1993;270:2813-2818.
20. Colditz GA, Sellers TA, Trapido E. Epidemiology - identifying the causes and preventability of cancer? Nat Rev Cancer. 2006;6(1):75-83.
21. Briss PA, Brownson RC, Fielding JE, Zaza S. Developing and using the Guide to Community Preventive Services: lessons learned about evidence-based public health. Annu Rev Public Health. 2004;25:281-302.
22. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 suppl):21-35.
23. Kawachi I, Colditz G, Stampfer M, et al. Smoking cessation and time course of decreased risk of coronary heart disease in women. Arch Intern Med. 1994;154(2):169-175.
24. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation in relation to total mortality rates in women: a prospective cohort study. Ann Intern Med. 1993;119(10):992-1000.
25. U.S. Department of Health and Human Services. Surgeon General's Report - Women and Smoking. Washington, DC: Government Printing Office; 2001.
26. Willett WC, Hennekens CH, Bain C, Rosner B, Speizer FE. Cigarette smoking and non-fatal myocardial infarction in women. Am J Epidemiol. 1981;113(5):575-582.
27. U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation. A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990. DHHS (CDC) 90-8416.
28. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.
29. Colditz GA, Bonita R, Stampfer MJ, et al. Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med. 1988;318(15):937-941.
30. Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst. 1997;89(13):948-955.
31. Kushi LH, Byers T, Doyle C, et al. American Cancer Society guidelines on nutrition and physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2006;56(5):254-281;quiz 313-314.
32. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006;24(22):3535-3541.
33. Pearson TA, Bazzarre TL, Daniels SR, et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation. 2003;107(4):645-651.
34. Emmons KM, McBride CM, Puleo E, et al. Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1453-1459.
35. Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Colditz GA. A prospective study of recreational physical activity and breast cancer risk. Arch Intern Med. 1999;159(19):2290-2296.
36. International Agency for Research on Cancer. Weight Control and Physical Activity. Lyon. France: International Agency for Research on Cancer; 2002.
37. Manson JE, Rimm EB, Stampfer MJ, et al. A prospective study of physical activity and the incidence of non-insulin-dependent diabetes mellitus in women. Lancet. 1991;338(8770):774-778.
38. Hu FB, Sigal RJ, Rich-Edwards JW, et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA. 1999;282(15):1433-1439.
39. American Diabetes Association. Diabetes prevention. http://www.diabetes. org/diabetes-prevention.jsp. Accessed October 2007.
40. Manson JE, Hu FB, Rich-Edwards JW, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med. 1999;341(9):650-658.
41. Krauss RM, Eckel RH, Howard B, et al. AHA dietary guidelines - revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke. 2000;31(11):2751-2766.
42. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst. 2000;92(15):1217-1227.
43. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. J Am Med Assoc. 1997;278(17):1407- 1411.
44. Doyle C, Kushi LH, Byers T, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2006;56(6):323-353.
45. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 2004;351(26):2694-2703.
46. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333(11):677-685.
47. U.S. Preventive Services Task Force. Screening for Obesity in Adults. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2003.
48. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol. 1990;132(3):501-513.
49. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289(14):1785-1791.
50. Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128(2):81-88.
51. American Academy of Pediatrics. Television and the Family. 2007. http://www.aap.org/family/tv1.htm.
52. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347(9017):1713-1727.
53. International Agency for Research on Cancer. Hormonal Contraception and Post-menopausal Hormonal Therapy. Lyon, France: IARC, WHO; 1999. Vol 72.
54. Willett WC, Bain C, Hennekens CH, Rosner B, Speizer FE. Oral contraceptives and risk of ovarian cancer. Cancer. 1981;48(7):1684-1687.
55. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332(24):1589-1593.
56. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
57. Hankinson SE, Willett WC, Manson JE, et al. Plasma sex steriod hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998;90:1292-1299.
58. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94(8):606-616.
59. Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev. 2002;11(2):195-201.
60. Harper-Wynne C, Ross G, Sacks N, et al. Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention. Cancer Epidemiol Biomarkers Prev. 2002;11(7):614-621.
61. Guerrieri-Gonzaga A, Robertson C, Bonanni B, et al. Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women. J Clin Oncol. 2006;24(1):129-135.
62. Kaaks R, Bellati C, Venturelli E, et al. Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr. 2003;57(9):1079-1088.
63. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2003;12(8):721-727.
64. Juul A, Bernasconi S, Carel JC, Clayton PE, Kiess W, DeMuinck-Keizer Schrama S. Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). Horm Res. 2003;60(2):103-104.
65. London ST, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. J Am Med Assoc. 1992;267(7):941-944.
66. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341:581-585.
67. Chardigny JM, Malpuech-Brugere C, Dionisi F, et al. Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans. Contemp Clin Trials. 2006;27(4):364-373.
68. Food and Drug Administration (Docket No. 95P-0197). Food labeling: health claims; oats and coronary heart disease. Fed Regist. 1997;62:3584-3601.
69. Giovannucci E, Stampfer M, Colditz G, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med. 1998;129:517-524.
70. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):2479-2486.
71. U.S. Preventive Services Task Force. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med. 2005;142(10):844-860.
72. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343(1):16-22.
73. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control. 1994;5(1):73-82.
74. Byers T, Nestle M, McTiernan A, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2002;52(2):92-119.
75. Klein EA. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial. Recent Results Cancer Res. 2003;163:212-225; discussion 264-266.
76. Sorensen G, Stoddard AM, LaMontagne AD, et al. A comprehensive worksite cancer prevention intervention: behavior change results from a randomized controlled trial (United States). J Public Health Policy. 2003;24(1):5-25.
77. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifetsyle, and risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790-797.
78. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180-187.
79. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886.
80. Freedman AN, Seminara D, Gail MH, et al. Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst. 2005;97(10):715-723.
81. Colditz G, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol. 2000;152(10):950-964.
82. Rosner B, Colditz G, Webb P, Hankinson S. Mathematical models of ovarian cancer incidence in the Nurses' Health Study. Epidemiology. 2004;16(4):508-515.
83. Cho E, Rosner BA, Feskanich D, Colditz GA. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol. 2005;23(12):2669- 2675.
84. Glasziou PP, Irwig LM. An evidence based approach to individualising treatment. BMJ. 1995;311:1356-1359.
85. Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002;287(1):47-54.
86. Feskanich D, Willett WC, Colditz GA, Calcium vitamin D, milk consumption. hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr. 2003;77(2):504-511.
87. Hennekens CH, Burling JE. Epidemiology in Medicine. Boston, MA: Little, Brown and Co.; 1987.
88. Hofman A. The Incidence of Major Diseases in the Elderly, The Rotterdam Study 1990-2004. Rotterdam, The Netherlands: Erasmus University; 2004.
89. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med. 1995;332(19):1245-1250.
90. Rockhill B, Willett WC, Manson JE, et al. Physical activity and mortality: a prospective study among women. Am J Public Health. 2001;91(4):578-583.
91. Colditz GA. Oral contraceptive use and mortality during twelve years of follow-up: the Nurse' Health Study. Ann Intern Med. 1994;120(10):821-826.
92. McCullough ML, Feskanich D, Stampfer MJ, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr. 2002;76(6):1261-1271.
93. Collaborative group on hormonal factors in breast cancer. Breast cancer and hormone replacement therapy. Combined reanalysis of data from 51 epidemiological studies involving 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997;350(9084):1047-1059.
94. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606-616.
95. Hunter DJ, Riboli E, Haiman CA, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005;5(12):977-985.
96. Giovannucci E, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control. 1996;7(2):253-263.
97. Irwin ML, Yasui Y, Ulrich CM, et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA. 2003;289(3):323-330.
98. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370-1378.
99. Klein S, Sheard NF, Pi-Sunyer X, et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004;80(2):257-263.
100. Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2004;110(18):2952-2967.
101. International Agency for Research on Cancer. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Human. Vol. 99 Lyon, France: IARC, 2007. http://monographs.iarc.fr/ENG/ Monographs/vol91/index.php. Accessed June 16, 2008.